FHL3在肺癌中的表达及机制探讨

Expression of FHL3 in lung cancer and its mechanism

  • 摘要: 目的 探讨FHL3在肺癌中的表达及其可能机制。 方法 收集我院胸外科手术切除的新鲜肺癌组织及正常肺组织标本共70对。分别行兔抗人FHL3抗体Western blotting分析及免疫组织化学染色,比较癌组织与正常肺组织之间FHL3表达差异。培养收集肺癌细胞及人胚肺细胞,行FHL3抗体的Western blotting分析。 结果 与正常肺组织相比,FHL3在腺癌中表达显著升高(0.74 vs 0.28,P<0.05)。FHL3在肺癌中的表达与性别、病理类型及TNM分期有关,与年龄、分化程度、肿瘤大小等无关。FHL3在两个高度恶性的腺癌细胞株Calu-3和H1299中表达水平升高。 结论 FHL3在肺腺癌中表达水平升高,FHL3可能在肺腺癌发病过程中起转录调节作用。

     

    Abstract: Objective To study the expression of LIM domain 3(FHL3) in lung cancer and its possible mechanism. Methods Seventy fresh lung cancer and normal lung tissue samples were collected during operation in our department.Rabbit anti-human FHL3 antibody was detected by Western blotting with immunohistochemical staining.Expressions of FHL3 in lung cancer and normal lung tissues were compared.Lung cancer cells and human embryonic lung cells were cultured and analyzed by Western blotting. Results The expression of FHL3 in lung cancer tissue was correlated with the gender of patients,pathologic type and TNM classification of lung cancer but not with the age of patients,differentiation and size of lung cancer.The expression level of FHL3 was significantly higher in adenocarcinoma tissue than in normal lung tissue.FHL3 was over-expressed in 2 highly malignant cell lines,Calu-3 and H1299. Conclusion FHL3 expression is up-regulated in lung adenocarcinoma tissue and may play a role in transcription regulation of lung adenocarcinoma.

     

/

返回文章
返回